This announcement is a separate document:
国金证券股份有限公司关于奥翔药业非公开发行股票发行过程和认购对象合规性的报告
Report of Guojin Securities Co., Ltd. on Aoxiang Pharmaceutical's non-public stock issuance process and the compliance of subscribers
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.